COVID–19 and Pandemic Response Centers of Excellence Act

General issues related to pandemic response: all provisions. H.R. 4292/S.2307, the COVID-19 and Pandemic Response Centers of Excellence Act: all provisions. S.340/H.R.4791 "Telehealth Response for E-prescribing Addiction Therapy Services Act"; all provisions.

Client expense: $66,297 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

COVID-19 response General hospital policies H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act; S. 2307 - COVID-19 and Pandemic Response Centers of Excellence Act of 2021. S. 3799 - PREVENT Pandemics Act. National Cancer Center Federal Designation. Inflation Reduction Act (H.R. 5376) Public Law No. 117-169. H.R. 6833 - Continuing Resolution.

Client expense: Not reported · Firm income: $50,000

COVID-19 relief P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence Veterans Affairs Community Care H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act H.R. 959 - Black Maternal Health Momnibus Act H.R. 4128, S. 2209 - VALID Act H.R. 4151, S. 2238 - FASD Respect Act S. 4348 - FDA Safety and Landmark Advancement Act H.R. 7667 - Food And Drug Amendments of 2022 H.R. 8747 - Assistance for Rural Community Hospitals (ARCH) Act (H.R.8747 S. 4009 - Assistance for Rural Hospital Support Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5699 & S. 2114, The Student Assisted Vaccination Effort (SAVE) Act: all provisions. General issues related to pandemic response: all provisions. H.R. 4292/S.2307, the COVID-19 and Pandemic Response Centers of Excellence Act: all provisions. S.340/H.R.4791 "Telehealth Response for E-prescribing Addiction Therapy Services Act"; all provisions.

Client expense: $93,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Met with legislative staff to express support for biomedical research. Urged legislative staff to cosponsor the RISE Act (HR 869, S 289) to authorize supplemental funding to NIH to cover extraordinary COVID-19-related costs to biomedical research. Urged legislative staff to support a proposal to create and fund a COVID-19 and Pandemic Response Centers of Excellence program (HR 4292, S 2307). Urged legislative staff to support S 168/HR 708, the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. Urged legislative staff to address telehealth provisions CMS identified as under Congress purview including audio-only visits and the ability for telehealth services to be provided to both new and established patients for acute and chronic conditions. Urged agency staff to create a dedicated fund within the provider relief fund to provide relief to faculty practice plans. Asked Representatives to consider legislation that makes changes to the regulation of laboratory testing (including the VALID Act) separately from the Medical Device User Fee Agreement (MDUFA) V legislative process.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

COVID-19 relief P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence Veterans Affairs Community Care H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act H.R. 959 - Black Maternal Health Momnibus Act H.R. 4128, S. 2209 - VALID Act H.R. 4151, S. 2238 - FASD Respect Act S. 4348 - FDA Safety and Landmark Advancement Act H.R. 7667 - Food And Drug Amendments of 2022

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

COVID-19 response General hospital policies H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act; S. 2307 - COVID-19 and Pandemic Response Centers of Excellence Act of 2021. H.R. 5376 - Build Back Better Act. S. 3799 - PREVENT Pandemics Act. National Cancer Center Federal Designation.

Client expense: Not reported · Firm income: $50,000

Met with legislative staff to express support for full funding of the National Institutes of Health, the Agency for Healthcare Research & Quality (AHRQ), and the Title VII Health Professions Programs, in the FY 22 budget and appropriations process. (PL 117-103, Division H) Met with legislative staff to express support for biomedical research. Urged legislative staff to cosponsor the RISE Act (HR 869, S 289) to authorize supplemental funding to NIH to cover extraordinary COVID-19-related costs to biomedical research. Urged legislative staff to support a proposal to create and fund a COVID-19 and Pandemic Response Centers of Excellence program (HR 4292, S 2307). Urged legislative staff to support S 168/HR 708, the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. Urged legislative staff to address telehealth provisions CMS identified as under Congress purview including audio-only visits and the ability for telehealth services to be provided to both new and established patients for acute and chronic conditions. Urged agency staff to create a dedicated fund within the provider relief fund to provide relief to faculty practice plans. Asked Representatives to consider legislation that makes changes to the regulation of laboratory testing (including the VALID Act) separately from the Medical Device User Fee Agreement (MDUFA) V legislative process.

Client expense: $140,000 · Firm income: Not reported

H.R. 5699 & S. 2114, The Student Assisted Vaccination Effort (SAVE) Act: all provisions General issues related to pandemic response: all provisions H.R. 4292/S.2307, the COVID-19 and Pandemic Response Centers of Excellence Act: all provisions S.340/H.R.4791 "Telehealth Response for E-prescribing Addiction Therapy Services Act": all provisions

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

COVID-19 response General hospital policies H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act; S. 2307 - COVID-19 and Pandemic Response Centers of Excellence Act of 2021. H.R. 5376 - Build Back Better Act. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). S. 3799 - PREVENT Pandemics Act. H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.

Client expense: Not reported · Firm income: $50,000

COVID-19 relief P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act H.R. 959 - Black Maternal Health Momnibus Act H.R. 4128, S. 2209 - VALID Act H.R. 4151, S. 2238 - FASD Respect Act

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to pandemic response H.R. 4292/S.2307, the COVID-19 and Pandemic Response Centers of Excellence Act All provisions

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Met with legislative staff to express support for full funding of the National Institutes of Health, the Agency for Healthcare Research & Quality (AHRQ), and the Title VII Health Professions Programs, in the FY 22 budget and appropriations process. (HR 4502) Met with legislative staff to express support for biomedical research. Urged legislative staff to cosponsor the RISE Act (HR 869, S 289) to authorize supplemental funding to NIH to cover extraordinary COVID-19-related costs to biomedical research. Urged legislative staff to include funding and express language to provide relief for providers in hot spot areas directly addressing the COVID-19 pandemic. Urged legislative staff to support a proposal to create and fund a COVID-19 and Pandemic Response Centers of Excellence program (HR 4292, S 2307). Urged legislative staff to support S 168/HR 708, the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. Urged legislative staff to address telehealth provisions CMS identified as under Congress purview including audio-only visits and the ability for telehealth services to be provided to both new and established patients for acute and chronic conditions. Urged agency staff to create a dedicated fund within the provider relief fund to provide relief to faculty practice plans.

Client expense: $90,000 · Firm income: Not reported

P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act H.R. 959 - Black Maternal Health Momnibus Act

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

COVID-19 response General hospital policies H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act; S. 2307 - COVID-19 and Pandemic Response Centers of Excellence Act of 2021. H.R. 5376 - Build Back Better Act.

Client expense: Not reported · Firm income: $50,000

S. 2307 and H.R. 4292, COVID-19 and Pandemic Centers of Excellence ActAll Provisions

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Met with legislative staff to express support for full funding of the National Institutes of Health, the Agency for Healthcare Research & Quality (AHRQ), and the Title VII Health Professions Programs, in the FY 22 budget and appropriations process. (HR 4502) Met with legislative staff to express support for biomedical research. Urged legislative staff to cosponsor the RISE Act (HR 869, S 289) to authorize supplemental funding to NIH to cover extraordinary COVID-19-related costs to biomedical research. Urged legislative staff to include funding and express language to provide relief for providers in hot spot areas directly addressing the COVID-19 pandemic. Urged legislative staff to support a proposal to create and fund a COVID-19 and Pandemic Response Centers of Excellence program (HR 4292, S 2307). Urged legislative staff to support S 168/HR 708, the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. Urged legislative staff to address telehealth provisions CMS identified as under Congress purview including audio-only visits and the ability for telehealth services to be provided to both new and established patients for acute and chronic conditions. Urged agency staff to create a dedicated fund within the provider relief fund to provide relief to faculty practice plans.

Client expense: $120,000 · Firm income: Not reported

S. 2307 and H.R. 4292, COVID-19 and Pandemic Centers of Excellence ActAll Provisions

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

COVID-19 response General hospital policies H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act; S. 2307 - COVID-19 and Pandemic Response Centers of Excellence Act of 2021. The Build Back Better Act, A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022 S. Con. Res. 14.

Client expense: Not reported · Firm income: $50,000

P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act H.R. 959 - Black Maternal Health Momnibus Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2307 and H.R. 4292 - COVID-19 and Pandemic Centers of Excellence Act; Calls with staff of Rep. Beatty, and Balderson, and Sens. Brown, Portman, and Gillibrand; also pandemic centers of excellence appropriations request H.R. 1319, American Rescue Plan Act implementation H.R. 1868, Medicare sequestration fix H.R. 708/ S 168, Temporary Reciprocity to Ensure Access to Treatment Act (TREAT Act) S 834, Resident Physician Shortage Reduction Act Maintain the 340B drug pricing program (no current bill) Support H.R. 1550, Prevent HPV Cancer Act of 2021 (with the ADCC) Comments submitted on the FY 2022 Medicare Inpatient Prospective Payment System Proposed Rule development of H.R. 4347, Balderson remote patient monitoring legislation General IssuesMaintaing the 340B drug pricing program; all provisions General Issues Medicare Hospital Outpatient Prospective Payment System (OPPS) CY 2019; provisions related to cuts to hospital outpatient departments S.4791 "Telehealth Response for E-prescribing Addiction Therapy Services Act (S.340)" H.R. 8474 All Provisions

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

H.R.865-Americans Jobs Plan Act H.R.4292-To provide for the establishment of COVID-19 and pandemic response centers of excellence, and for other purposes. H.R.144-Supporting Early-Career Researchers Act S.610/H.R.1667-Dr. Lorna Breen Health Care Provider Protection Act

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

Met with legislative staff to express support for full funding of the National Institutes of Health, the Agency for Healthcare Research & Quality (AHRQ), and the Title VII Health Professions Programs, in the FY 22 budget and appropriations process. (No bill number) Met with legislative staff to express support for biomedical research. Urged legislative staff to cosponsor the RISE Act (HR 869, S 289) to authorize supplemental funding to NIH to cover extraordinary COVID-19-related costs to biomedical research. Urged legislative staff to include funding and express language to provide relief for providers in hot spot areas directly addressing the COVID-19 pandemic. Urged legislative staff to support a proposal to create and fund a COVID-19 and Pandemic Response Centers of Excellence program (HR 4292, S 2307). Urged legislative staff to support S 168/HR 708, the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. Urged legislative staff to address telehealth provisions CMS identified as under Congress purview including audio-only visits and the ability for telehealth services to be provided to both new and established patients for acute and chronic conditions. Urged agency staff to create a dedicated fund within the provider relief fund to provide relief to faculty practice plans.  

Client expense: $130,000 · Firm income: Not reported

COVID-19 response General hospital policies H.R. 186; P.O. 117-7. H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act;

Client expense: Not reported · Firm income: $50,000

COVID-19 relief P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

340B Drug Discount Program S. 384 Resident Physician Shortage Reduction Act Graduate Medical Education Disproportionate Share Hospital payments Childrens Health Insurance Program Medicare Dependent Hospital Program (MDH) Medicaid Low Volume Payments (LV) Federal Medical Assistance Percentage Extension Inpatient Prospective Payment System Outpatient Prospective Payment System Bad debt/charity care Hospital Outpatient Department payments CMS Accelerated and Advanced Payments COVID-19 Relief H.R. 1868, S. 748 - Medicare Sequester Relief Act H.R. 4292, S. 773 - 340B Drug Program DSH eligibility extension

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE